Cardiovascular Kidney Metabolic

EU Clears Plozasiran for FCS, Opening Door to Clinical Diagnosis-Based Use

Radcliffe CKM

Broadcast

Cardiovascular Kidney Metabolic
The VITAL Initiative

Carel Le Roux, Lee Kaplan, Sue Pedersen , et al

Broadcast

Cardiovascular Kidney Metabolic
Reframing Disease: From Weight to Metabolic Dysfunction

Carel Le Roux, Lee Kaplan, Sue Pedersen , et al

Muthiah Vaduganathan, Neha Pagidipati, Smeeta Sinha, et al

Watch time: 4h 37m 26s (7 videos)

Smeeta Sinha, Navdeep Tangri, Brendon Neuen, et al

Watch time: 46m 8s (4 videos)
Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m

Angela Fitch, Richard Hobbs, Nikolaus Marx, et al

Watch time: 7h 41m 27s (10 videos)

Asaad Hussein, Mohammad Eisa Ali, Venkata Kanishk Yannakula, et al

Read time: 31m 40s

Richard Hobbs, Lydia Alexander, Sean Wharton, et al

Watch time: 43m 12s (4 videos)
ERA 26: TURING: Rituximab in Adult MCD and FSGS

Lisa Willcocks

Watch time: 8m 44s
Heart Failure in the Cardio-Renal-Metabolic Patient: Front-Line Decisions

Debasish Banerjee

Watch time: 9m 42s

Dario Pitocco, Martina Cortelletti, Giovanna Petrucci, et al

Read time: 25m

Richard Hobbs, Lydia Alexander, Sean Wharton, et al

Watch time: 43m 12s (4 videos)

Erin D Michos, Christie Ballantyne

Watch time: 8m 4s (10 videos)
Top Takeaways from the 2026 Dyslipidaemia Guidelines

Ann Marie Navar

Watch time: 5m 8s

Andrew JS Coats, Stefan Anker

Angela Fitch, Richard Hobbs, Nikolaus Marx, et al

Watch time: 7h 41m 27s (10 videos)

Muthiah Vaduganathan, Neha Pagidipati, Smeeta Sinha, et al

Watch time: 4h 37m 26s (7 videos)

Smeeta Sinha, Navdeep Tangri, Brendon Neuen, et al

Watch time: 46m 8s (4 videos)

David Tak Wai Lui, Junya Ako, Jamshed Dalal, et al

Read time: 20m 26s

Shubh K Patel, Hwee Teoh, Ahreni Saunthar, et al

Read time: 24m 34s

Asaad Hussein, Mohammad Eisa Ali, Venkata Kanishk Yannakula, et al

Read time: 31m 40s
Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s

Media

Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m

Erin D Michos, Christie Ballantyne

Watch time: 8m 4s (10 videos)

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
KDIGO GEMs - Glomerular Diseases

Brad Rovin, Jürgen Floege, Silke Brix , et al

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 18m (7 videos)

Fausto J Pinto, John Spertus, , et al

Watch time: 2s (19 videos)
Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s

Media

Broadcast

Cardiovascular Kidney Metabolic
Reframing Disease: From Weight to Metabolic Dysfunction

Carel Le Roux, Lee Kaplan, Sue Pedersen , et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
New Horizons in Obesity Management 2026

Angela Fitch, Richard Hobbs, Nikolaus Marx

Broadcast

Cardiovascular Kidney Metabolic
The VITAL Initiative

Carel Le Roux, Lee Kaplan, Sue Pedersen , et al

Erin D Michos, Christie Ballantyne

Watch time: 8m 4s (10 videos)

Richard Hobbs, Lydia Alexander, Sean Wharton, et al

Watch time: 43m 12s (4 videos)

Smeeta Sinha, Navdeep Tangri, Brendon Neuen, et al

Watch time: 46m 8s (4 videos)

Muthiah Vaduganathan, Neha Pagidipati, Smeeta Sinha, et al

Watch time: 4h 37m 26s (7 videos)
Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m

Angela Fitch, Richard Hobbs, Nikolaus Marx, et al

Watch time: 7h 41m 27s (10 videos)
ERA 26: TURING: Rituximab in Adult MCD and FSGS

Lisa Willcocks

Watch time: 8m 44s

Broadcast

Cardiovascular Kidney Metabolic
New Horizons in Cardio Kidney Disease

Muthiah Vaduganathan, Neha Pagidipati, Smeeta Sinha

Heart Failure in the Cardio-Renal-Metabolic Patient: Front-Line Decisions

Debasish Banerjee

Watch time: 9m 42s

Articles

Gaps in Modern Heart Failure and Chronic Kidney Disease Research

Simran Singh Parmar

,

Vasantha Muthuppalaniappan

,

Debasish Banerjee

,

Published:

23 August 2023

Citation:

European Cardiology Review 2023;18:e51.

DOI:

https://doi.org/10.15420/ecr.2022.64
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 129
  • Citations: 9
  • Read time: 5m

Cardiometabolic Risk Factors and COVID-19 in the Asia-Pacific Region

Ru Ying Fong

,

Annie Lee

,

Fei Gao

,

Jonathan Jiunn Liang Yap

,

Khung Keong Yeo

,

Published:

23 June 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e22.

DOI:

https://doi.org/10.15420/japsc.2022.27
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 18
  • Citations: 2
  • Read time: 18m

Timing of SGLT2 Inhibitors in Heart Failure

Moritake Iguchi

,

Hiromichi Wada

,

Felipe Martínez

,

Koji Hasegawa

,

Published:

07 June 2023

Citation:

European Cardiology Review 2023;18:e41.

DOI:

https://doi.org/10.15420/ecr.2022.62
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 219
  • Citations: 3
  • Read time: 9m 20s

Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease

Daciana Dascalu

,

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e23.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO6
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 45
  • Citations: 1
  • Read time: 1m